Q32 Bio Inc expected to post a loss of $1.18 a share - Earnings Preview

Q32 Bio

09/08/2024 17:31

* Q32 Bio Inc  QTTB.OQ   QTTB.O  is expected to show no
change in
quarterly revenue when it reports  results  for the period
ending September 30 2024
    * 
    * ​LSEG's mean analyst estimate for Q32 Bio Inc is for a
loss of
$1.18 per share. 
    * The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 4 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts had fallen by
about 4.8%
in the last three months. ​
    * Wall Street's median 12-month price target for Q32 Bio Inc
is
$57.00​, above​ its last closing price of $35.83. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  LSEG IBES  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  ESTIMATE             MET,    SE %
               E®                               MISSED  
 Jun. 30 2024  -1.05       -1.04      -1.42     Missed  -36.2
 Mar. 31 2024  -1.42       -2.32      -14.95    Missed  -543.5
 Dec. 31 2023  -5.40       -5.40      -5.04     Beat    6.7​
 Sep. 30 2023  -7.56       -7.56      -10.26    Missed  -35.7
 ​​Jun.        -8.94       -8.55      -10.98    Missed  -28.4
 30 2023                                                
 Mar. 31 2023  -9.71       -9.54      -9.00     Beat    5.7​
 Dec. 31 2022  -9.11       -9.07      -10.80    Missed  -19.1
 Sep. 30 2022  -8.58       -8.50      -10.62    Missed  -24.9
 This summary was machine generated August 9 at 16:31 GMT.  All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)